Trial Profile
Velcade - Regulatory Post Marketing Surveillance (PMS).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jun 2012
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- Acronyms Velcade PMS
- Sponsors Janssen
- 01 Jun 2012 Actual patient number 1121 added as reported by ClinicalTrials.gov.
- 01 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Feb 2012 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.